Rosenblum Silverman Sutton S F Inc Alnylam Pharmaceuticals, Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

$376 Million
Q3 2024

A detailed history of Rosenblum Silverman Sutton S F Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Rosenblum Silverman Sutton S F Inc holds 35,155 shares of ALNY stock, worth $8.28 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

35,155

Previous 35,200 0.13%

Holding current value

$8.28 Million

Previous $8.55 Million 13.06%

% of portfolio

2.57%

Previous 2.35%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $10,521 - $12,915	-45 Reduced 0.13%	35,155 $9.67 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $38,693 - $66,690	-270 Reduced 0.76%	35,200 $8.55 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $231,925 - $313,750	-1,583 Reduced 4.27%	35,470 $5.3 Million
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $17,077 - $21,165	-100 Reduced 0.27%	37,053 $6.56 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $72,153 - $82,699	-390 Reduced 1.04%	37,153 $7.06 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $472,358 - $609,080	-2,586 Reduced 6.44%	37,543 $7.52 Million
Q3 2022 Nov 15, 2022	SELL	$138.54 - $232.0 $343,163 - $574,664	-2,477 Reduced 5.81%	40,129 $8.03 Million
Q2 2022 Aug 10, 2022	BUY	$120.42 - $169.29 $101,754 - $143,050	845 Added 2.02%	42,606 $6.21 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $76,053 - $103,998	-598 Reduced 1.41%	41,761 $6.82 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $106,107 - $139,177	-665 Reduced 1.55%	42,359 $7.18 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $70,785 - $86,623	-417 Reduced 0.96%	43,024 $8.12 Million
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $70,231 - $96,581	546 Added 1.27%	43,441 $7.36 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $102,098 - $141,430	805 Added 1.91%	42,895 $6.06 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $28,897 - $34,545	235 Added 0.56%	42,090 $5.47 Million
Q3 2020 Nov 09, 2020	BUY	$121.19 - $165.49 $346,603 - $473,301	2,860 Added 7.33%	41,855 $6.09 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $138,078 - $207,283	1,325 Added 3.52%	38,995 $5.78 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $3.51 Million - $5.05 Million	37,670 New	37,670 $4.1 Million

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.

Account

Rosenblum Silverman Sutton S F Inc Alnylam Pharmaceuticals, Inc. Transaction History